Search results for "HEPATITIS"

showing 10 items of 1578 documents

Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic…

1996

Abstract Antibodies directed to the HBs antigen indicate viral clearance and the development of life-long immunity in patients that recovered from HBV infection. In HBs antigen vaccine recipients anti-HBs antibodies provide protective immunity. However, little is known about the regulation of this HBs-specific antibody response. The existence of anti-HBs-secreting B cells was demonstrated using the highly sensitive ELISPOT technique compared with conventional ELISA in serum and cell culture supernatants. In the peripheral blood of patients with acute self-limited hepatitis B, HBs-specific B cells were demonstrated with a high frequency despite undetectable anti-HBs serum antibodies. HBV-imm…

AdultMaleAdolescentT-LymphocytesImmunologymedicine.disease_cause03 medical and health sciences0302 clinical medicineImmune systemNeutralization TestsImmunityHumansImmunology and AllergyMedicineHepatitis B VaccinesHepatitis B AntibodiesRapid PublicationsB cellAgedHepatitis Chronic030304 developmental biologyHepatitis B virusB-LymphocytesImmunity Cellular0303 health sciencesHepatitis B Surface Antigensbiologybusiness.industryELISPOTvirus diseasesMiddle AgedHepatitis BHepatitis Bmedicine.diseasebiology.organism_classificationVirologydigestive system diseases3. Good healthmedicine.anatomical_structureHepadnaviridaeAcute DiseaseImmunologybiology.proteinFemale030211 gastroenterology & hepatologyAntibodybusinessClinical and Experimental Immunology
researchProduct

Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study.

1990

In a multicentre trial, 82 patients known to be hepatitis B e antigen and hepatitis B virus DNA positive for at least 1 year, with elevated serum alanine aminotransferase levels and chronic liver lesions on biopsy, were randomized to receive either recombinant interferon alfa-2a at a dose of 4.5 million units thrice weekly for 4 months or no treatment. At the end of therapy, viral DNA clearance and aminotransferase normalization were significantly (p less than 0.05) more frequent in treated patients than in controls. After 16 months' follow up, the difference was still significant for hepatitis B e antigen clearance and transaminase normalization. Hepatitis B virus DNA reactivation was obse…

AdultMaleAlpha interferonInterferon alpha-2medicine.disease_causeTransaminaseLiver diseaseInterferonBiopsymedicineHumanschronic hepatitis BHepatitis B e AntigensHepatitis B virustherapyHepatitis B Surface AntigensHepatologybiologymedicine.diagnostic_testbusiness.industryInterferon-alphaAlanine TransaminaseinterferonHepatitis Bmedicine.diseaseHepatitis BRecombinant ProteinsAlanine transaminaseLiverImmunologyChronic Diseasebiology.proteinFemalechronic hepatitis B; therapy; interferonbusinessBiomarkersmedicine.drugFollow-Up StudiesJournal of hepatology
researchProduct

Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis.

2002

Antibodies to soluble liver antigen/liver-pancreas are highly specific markers of type 1 autoimmune hepatitis that have been associated with relapse. Our aim was to determine if these antibodies are reflective of a genetic predisposition for recrudescent disease.One hundred forty-four white North American patients were evaluated by an enzyme immunoassay and by Western blot using recombinant soluble liver antigen/liver-pancreas; 122 were assessed for class II human leukocyte antigens (HLAs).Twenty-two patients (15%) had antibodies to soluble liver antigen/liver-pancreas. These patients were indistinguishable from seronegative patients by clinical, laboratory, and histological features at pre…

AdultMaleAnti-nuclear antibodyBlotting WesternEnzyme-Linked Immunosorbent AssayAutoimmune hepatitisHuman leukocyte antigenAutoantigensRisk AssessmentSensitivity and SpecificityStatistics NonparametricHLA-DR3 AntigenRisk FactorsmedicineHLA-DR4 AntigenHumansProbabilityAutoimmune diseaseHepatitisHepatologybiologybusiness.industryGastroenterologyPanel reactive antibodyPancreatic DiseasesMiddle Agedmedicine.diseaseHepatitis Autoimmunemedicine.anatomical_structureSolubilityAntibodies AntinuclearImmunologybiology.proteinDrug Therapy CombinationFemaleAntibodyPancreasbusinessThe American journal of gastroenterology
researchProduct

Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis.

1999

Abstract Background/Aims: Classification of autoimmune hepatitis (AIH) into different subgroups according to autoantibody status has been proposed: type I (ANA/SMA), type II (LKM-1) and type III (anti-SLA). However, whether type III AIH forms a clinically distinct disease entity remains controversial. The aim of this study was to evaluate the subclassification of AIH into ANA/SMA and anti-SLA positive patients with regard to clinical, biochemical and histologic differences. Methods: Ninety-seven consecutive patients with a well-documented long-term course of AIH with ANA/SMA and/or anti-SLA autoantibodies were studied. Clinical, biochemical and histological features of patients with ANA/SMA…

AdultMaleAnti-nuclear antibodyHLA-DR3Autoimmune hepatitisAutoantigensAutoimmune DiseasesHepatitisimmune system diseasesmedicineHumansClinical significanceAutoantibodiesAutoimmune diseaseHepatitisImmunosuppression TherapyHepatologybusiness.industryfungiAutoantibodyMuscle SmoothMiddle Agedmedicine.diseaseSMA*PrognosisAntibodies AntinuclearImmunologyFemalebusinessJournal of hepatology
researchProduct

C4A deficiency and nonresponse to hepatitis B vaccination

2002

Hepatitis B vaccination failure has been linked to the presence of certain human leukocyte antigen class II alleles. However, the functional background of these associations has remained unclear. Complement component C 4 is encoded within the major histocompatibility complex and is essential for classical pathway activation.Healthy individuals (n=4269) were vaccinated in a prospective trial with Engerix B. Nonresponse was classified as anti-HBs10 U/l after the last vaccination. Seventy-three nonresponders (NR) (1.7%) were identified. For comparison 53 responders (R) (anti-HBs10 IU/l) were drawn randomly from the same cohort. C4 allotyping was carried out by high-voltage agarose gel electrop…

AdultMaleBiologyMajor histocompatibility complexClassical complement pathwaySeroepidemiologic StudiesHumansHepatitis B VaccinesProspective StudiesTreatment FailureHepatitis B AntibodiesSouthern blotGel electrophoresisB-LymphocytesHepatologyHaplotypeComplement C4aHLA-DR AntigensMiddle AgedHepatitis BVirologyComplement systemLogistic ModelsHaplotypesAgarose gel electrophoresisImmunologybiology.proteinFemaleVaccine failureGene DeletionHLA-DRB1 ChainsJournal of Hepatology
researchProduct

Individual and common antigen-recognition sites of liver-derived T cells in patients with autoimmune hepatitis.

2003

Autoimmune hepatitis (AIH) is characterized by dense T-cell infiltrations in the liver tissue, but little is known how T cells influence the pathogenesis. To address this question, the distribution of T-cell receptor variable beta-chain (TCR Vbeta) transcripts of peripheral blood and liver-infiltrating T cells from previously untreated patients with newly diagnosed acute exacerbated AIH was investigated. Furthermore, the lengths and sequences of complementary-determining region 3 (CDR3) were studied. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis and CDR3 spectratyping revealed multiple clonal expansions of liver-infiltrating T cells but not peripheral T cells within vari…

AdultMaleBiopsyT-LymphocytesImmunologyMolecular Sequence DataReceptors Antigen T-CellEpitopes T-Lymphocytechemical and pharmacologic phenomenaInflammationAutoimmune hepatitisBiologyCDR3 SpectratypingEpitopePathogenesismedicineHumansAmino Acid SequenceRNA MessengerReceptorAgedBase SequenceReverse Transcriptase Polymerase Chain ReactionT-cell receptorhemic and immune systemsGeneral MedicineMiddle Agedmedicine.diseaseComplementarity Determining RegionsClone CellsHepatitis AutoimmuneGene Expression RegulationImmunologyFemalemedicine.symptomNested polymerase chain reactionScandinavian journal of immunology
researchProduct

Prevalence and genomic variability of transfusion transmitted virus in Italian cryptogenic chronic liver disease and healthy blood donors

2002

Abstract Background. Infection with transfusion transmitted virus, a new member of the Parvoviridae family, has been found in patients both with chronic and fulminant post-transfusion cryptogenic hepatitis. Aim. To evaluate the prevalence and clinical impact of transfusion transmitted virus infection in Italy. Patients and Methods. Studies were carried out on 256 patients and control subjects from three centres from Northern, Central and Southern Italy (92 nonA-nonC chronic hepatitis, 10 acute non fulminant cryptogenic hepatitis, 41 hepatitis C virus-related chronic hepatitis and 113 blood donors). Serum transfusion transmitted virus was detected by nested polymerase chain reaction using tw…

AdultMaleBlood transfusionAdolescentmedicine.medical_treatmentHepatitis C virusBlood Donorsblood transfusionmedicine.disease_causeVirusTransfusion transmitted virusLiver diseasetransfusion transmitted virusmedicinePrevalenceHumansAgedHepatitis ChronicHepatitis B virusHepatitisTorque teno virusblood transfusion; cryptogenic chronic liver disease; transfusion transmitted virusHepatologybiologybusiness.industryGastroenterologyHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseasebiology.organism_classificationVirologyDNA Virus InfectionsItalyImmunologyDNA ViralFemalebusinesscryptogenic chronic liver disease
researchProduct

Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1.

1997

Abstract Background/Aim: Anti-neutrophil cytoplasmic antibodies (ANCA) are a group of autoantibodies first associated with Wegener's granulomatosis and microscopic polyangiitis. The signifiance of ANCA in autoimmune hepatitis remains uncertain; the nature of the antigen or antigens has not been defined yet. The purpose of this study was to identify the target antigen of ANCA in patients with autoimmune hepatitis. Method/Results: Sera from 32 type-1 autoimmune hepatitis patients were used in the present study. ANCA were detected in 24 of 32 sera (75%). A diffuse cytoplasmic staining pattern (C-ANCA) was detected in 14 patients; the P-ANCA pattern was observed in 10 patients. An extract of hu…

AdultMaleBlotting WesternEnzyme-Linked Immunosorbent AssayAutoimmune hepatitisTropomyosinMyosinsAntibodies Antineutrophil CytoplasmicAutoimmune DiseasesHepatitisAntigenmedicineHumanscardiovascular diseasesAntigensFluorescent Antibody Technique IndirectAnti-neutrophil cytoplasmic antibodyAgedAutoimmune diseaseHepatitisAged 80 and overHepatologybiologyAutoantibodyActomyosinBlood ProteinsMiddle Agedmedicine.diseaseActinsMolecular WeightImmunologybiology.proteinFemaleAntibodyMicroscopic polyangiitisJournal of hepatology
researchProduct

New data from the Italian National Register of Congenital Coagulopathies, 2016 Annual Survey

2018

BACKGROUND: In Italy, the National Register of Congenital Coagulopathies (NRCC) collects epidemiological and therapeutic data from patients affected by haemophilia A (HA), haemophilia B (HB), von Willebrand’s disease (vWD) and other rare coagulation disorders. Here we present data from the 2016 annual survey. MATERIALS AND METHODS: Data are provided by the Italian Haemophilia Centres, on a voluntary basis. Information flows from every Centre to a web-based platform of the Italian Association of Haemophilia Centres, shared with the Italian National Institute of Health, in accordance with current privacy laws. Patients are classified by diagnosis, disease severity, age, gender and treatment-r…

AdultMaleCanadaAdolescentAdolescent Adult Aged Blood Coagulation Factors Canada Child Coagulation Protein Disorders Factor IX Factor VIII Female France HIV Infections Hemophilia A Hemophilia B Hepatitis CHumans Infant Infant Newborn Italy Male Middle Aged Prevalence Registries Surveys and Questionnaires United Kingdom von Willebrand DiseasesHIV InfectionsCoagulation Protein DisordersHemophilia AHemophilia BFactor IXhemic and lymphatic diseasesSurveys and QuestionnairesPrevalenceHumansRegistriesChildAgedFactor VIIIInfant NewbornInfantMiddle AgedHepatitis CBlood Coagulation FactorsUnited Kingdomvon Willebrand DiseasesItalyChild PreschoolFemaleOriginal ArticleFrance
researchProduct

Effect of antiviral treatment and host susceptibility on positive selection in hepatitis C virus (HCV).

2007

Abstract We have conducted a large sequence study of the E1–E2 and NS5A regions of the HCV, subtypes 1a and b, both in patients previously treated with interferon, and untreated patients, who later responded, or not, to a combination therapy based on interferon plus ribavirin. We have examined the role played by the number of positively selected sites on disease progression and its relationship with several variables such as patients’ age, sex and their risk of acquiring the disease. We have detected three groups of patients that respond or not to combination therapy: responders of intermediate age, older non-responders and young non-responders, they possess an increasing average number of …

AdultMaleCancer ResearchCombination therapyHepatitis C virusMolecular Sequence DataDiseaseHepacivirusBiologyViral Nonstructural Proteinsmedicine.disease_causeAntiviral Agentschemistry.chemical_compoundViral Envelope ProteinsInterferonVirologyRibavirinmedicineHumansAmino Acid SequenceSelection GeneticNS5AAgedHost (biology)Positive selectionRibavirinSequence Analysis DNAMiddle AgedHepatitis CInfectious DiseasesTreatment OutcomechemistryAmino Acid SubstitutionImmunologyRNA ViralFemaleInterferonsmedicine.drugVirus research
researchProduct